Cheng Chang

1.5k total citations
33 papers, 1.1k citations indexed

About

Cheng Chang is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Cheng Chang has authored 33 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 8 papers in Cancer Research and 4 papers in Surgery. Recurrent topics in Cheng Chang's work include Cancer-related molecular mechanisms research (5 papers), Heat shock proteins research (5 papers) and RNA Research and Splicing (5 papers). Cheng Chang is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), Heat shock proteins research (5 papers) and RNA Research and Splicing (5 papers). Cheng Chang collaborates with scholars based in United States, China and Sweden. Cheng Chang's co-authors include Arthur M. Mercurio, Bryan Pursell, Hira Lal Goel, Dale L. Greiner, Leonard D. Shultz, Wei Li, Xinbo Yu, Mei Chen, Jens Henrik Norum and Rune Toftgård and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Genes & Development and Molecular and Cellular Biology.

In The Last Decade

Cheng Chang

33 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cheng Chang United States 19 762 319 268 184 111 33 1.1k
Adam Geber United States 11 762 1.0× 502 1.6× 426 1.6× 102 0.6× 156 1.4× 13 1.4k
Giovanna Grimaldi Italy 22 1.5k 2.0× 274 0.9× 368 1.4× 163 0.9× 194 1.7× 44 2.0k
Ravi Misra United States 19 1.1k 1.5× 139 0.4× 184 0.7× 108 0.6× 180 1.6× 37 1.6k
Kristi L. Neufeld United States 24 1.7k 2.2× 448 1.4× 212 0.8× 229 1.2× 98 0.9× 41 2.1k
Henry Heinsohn United States 6 923 1.2× 154 0.5× 169 0.6× 72 0.4× 50 0.5× 6 1.1k
László Szilák Hungary 19 753 1.0× 107 0.3× 170 0.6× 361 2.0× 66 0.6× 41 1.3k
Jifang Wen China 22 833 1.1× 236 0.7× 437 1.6× 67 0.4× 123 1.1× 62 1.3k
Hélène Bœuf France 25 1.2k 1.6× 521 1.6× 174 0.6× 218 1.2× 264 2.4× 39 1.8k
Panagiotis Katsoris Greece 19 653 0.9× 140 0.4× 236 0.9× 307 1.7× 129 1.2× 49 1.1k
Young Ae Joe South Korea 21 752 1.0× 141 0.4× 256 1.0× 58 0.3× 88 0.8× 56 1.2k

Countries citing papers authored by Cheng Chang

Since Specialization
Citations

This map shows the geographic impact of Cheng Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng Chang more than expected).

Fields of papers citing papers by Cheng Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheng Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng Chang. The network helps show where Cheng Chang may publish in the future.

Co-authorship network of co-authors of Cheng Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Cheng Chang. A scholar is included among the top collaborators of Cheng Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheng Chang. Cheng Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chang, Cheng, et al.. (2024). Previously unrecognized and potentially consequential challenges facing Hsp90 inhibitors in cancer clinical trials. Cell Stress and Chaperones. 29(5). 642–653. 3 indexed citations
2.
Chen, Mei, et al.. (2023). Why Are There So Few FDA-Approved Therapeutics for Wound Healing?. International Journal of Molecular Sciences. 24(20). 15109–15109. 17 indexed citations
3.
Chang, Cheng, et al.. (2023). Group-shrinkage feature selection with a spatial network for mining DNA methylation data. Computers in Biology and Medicine. 154. 106573–106573. 2 indexed citations
4.
Chang, Cheng, et al.. (2023). Effects of Subchronic Propofol Administration on the Proliferation and Differentiation of Neural Stem Cells in Rat Hippocampus. Current Therapeutic Research. 98. 100691–100691. 3 indexed citations
5.
Chang, Cheng, Xinbo Yu, Chaoyi Guo, et al.. (2023). Engineered M13 phage as a novel therapeutic bionanomaterial for clinical applications: From tissue regeneration to cancer therapy. Materials Today Bio. 20. 100612–100612. 42 indexed citations
6.
Yu, Xinbo, et al.. (2022). Primary implant stability based on alternative site preparation techniques: A systematic review and meta‐analysis. Clinical Implant Dentistry and Related Research. 24(5). 580–590. 13 indexed citations
7.
Feng, Jian, Jing Wang, Weihong Lin, et al.. (2022). MPZL1 upregulation promotes tumor metastasis and correlates with unfavorable prognosis in non-small cell lung cancer. Carcinogenesis. 43(10). 919–929. 8 indexed citations
8.
Cui, Guoliang, Can Wang, Jinhui Liu, et al.. (2022). Development of an exosome-related and immune microenvironment prognostic signature in colon adenocarcinoma. Frontiers in Genetics. 13. 995644–995644. 7 indexed citations
9.
Chang, Cheng, et al.. (2022). LRP-1 receptor combines EGFR signalling and eHsp90α autocrine to support constitutive breast cancer cell motility in absence of blood supply. Scientific Reports. 12(1). 12006–12006. 6 indexed citations
10.
Chang, Cheng, et al.. (2021). Heat shock protein-90alpha (Hsp90α) stabilizes hypoxia-inducible factor-1α (HIF-1α) in support of spermatogenesis and tumorigenesis. Cancer Gene Therapy. 28(9). 1058–1070. 28 indexed citations
11.
Chang, Cheng, et al.. (2020). Wound Healing Driver Gene and Therapeutic Development: Political and Scientific Hurdles. Advances in Wound Care. 10(8). 415–435. 9 indexed citations
12.
Chang, Cheng, et al.. (2019). ELK1‐induced upregulation of lncRNA TRPM2‐AS promotes tumor progression in gastric cancer by regulating miR‐195/ HMGA1 axis. Journal of Cellular Biochemistry. 120(10). 16921–16933. 41 indexed citations
13.
Elaimy, Ameer L., Santosh Kumar Guru, Cheng Chang, et al.. (2018). VEGF–neuropilin-2 signaling promotes stem-like traits in breast cancer cells by TAZ-mediated repression of the Rac GAP β2-chimaerin. Science Signaling. 11(528). 54 indexed citations
14.
Ding, Yi, et al.. (2017). Adrenal venous sampling as used in a patient with primary pigmented nodular adrenocortical disease. Translational Cancer Research. 6(6). 1117–1122. 1 indexed citations
15.
Shen, Liping, Cheng Chang, Xueqing Zhang, et al.. (2016). Long noncoding RNA lnc-RI is a new regulator of mitosis via targeting miRNA-210-3p to release PLK1 mRNA activity. Scientific Reports. 6(1). 25385–25385. 18 indexed citations
16.
Chang, Cheng, Hira Lal Goel, Huijie Gao, et al.. (2015). A laminin 511 matrix is regulated by TAZ and functions as the ligand for the α6Bβ1 integrin to sustain breast cancer stem cells. Genes & Development. 29(1). 1–6. 132 indexed citations
17.
Mak, Paul, Jiarong Li, Sanjoy Samanta, et al.. (2015). Prostate Tumorigenesis Induced by PTEN Deletion Involves Estrogen Receptor β Repression. Cell Reports. 10(12). 1982–1991. 23 indexed citations
18.
Niu, Gengming, LiuLiang Qin, Cheng Chang, et al.. (2014). Orphan nuclear receptor TR3/Nur77 improves wound healing by upregulating the expression of integrin β4. The FASEB Journal. 29(1). 131–140. 37 indexed citations
19.
Chang, Cheng, Xiaofang Yang, Bryan Pursell, & Arthur M. Mercurio. (2013). Id2 Complexes with the SNAG Domain of Snai1 Inhibiting Snai1-Mediated Repression of Integrin β4. Molecular and Cellular Biology. 33(19). 3795–3804. 24 indexed citations
20.
Goel, Hira Lal, Cheng Chang, Bryan Pursell, et al.. (2012). VEGF/Neuropilin-2 Regulation of Bmi-1 and Consequent Repression of IGF-IR Define a Novel Mechanism of Aggressive Prostate Cancer. Cancer Discovery. 2(10). 906–921. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Adam Geber Breakdown of academic impact, for papers by Giovanna Grimaldi Breakdown of academic impact, for papers by Ravi Misra Breakdown of academic impact, for papers by Kristi L. Neufeld Breakdown of academic impact, for papers by Henry Heinsohn Breakdown of academic impact, for papers by László Szilák Breakdown of academic impact, for papers by Jifang Wen Breakdown of academic impact, for papers by Hélène Bœuf Breakdown of academic impact, for papers by Panagiotis Katsoris Breakdown of academic impact, for papers by Young Ae Joe
Rankless by CCL
2026